Cordyceps Sunshine Biotech Holdings (RAJAF) Capital Expenditures (2023)

Cordyceps Sunshine Biotech Holdings (RAJAF) recorded quarterly Capital Expenditures of $1.9 million in Q4 2023.

Cordyceps Sunshine Biotech Holdings (RAJAF) Capital Expenditures (2023) Analysis & Trends

Cordyceps Sunshine Biotech Holdings' Capital Expenditures history runs 1 years deep, the most recent figure standing at $1.9 million for Q4 2023.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Capital Expenditures (Qtr)
1 Paranovus Entertainment Technology 75,216.52 Bn 75,216.52 Bn - -
2 Kraft Heinz 26.76 Bn 22.68 Bn 2.22 Bn 240.00 Mn
3 General Mills 17.79 Bn 17.02 Bn 1.37 Bn 102.40 Mn
4 Jbs 13.93 Bn 9.37 Bn 2.32 Bn -566.40 Mn
5 Hormel Foods 13.00 Bn 12.16 Bn 518.51 Mn -1.96 Mn
6 Mccormick 12.70 Bn 13.10 Bn 708.90 Mn 32.50 Mn
7 Magnum Ice Cream 12.17 Bn 11.70 Bn - -415.56 Mn
8 J M Smucker 11.05 Bn 10.99 Bn 827.80 Mn 71.50 Mn
9 Smithfield Foods 10.57 Bn 9.49 Bn 511.00 Mn 88.00 Mn
10 Cordyceps Sunshine Biotech Holdings - - - -

Historic Data

Download Data
DateValue
Dec 31, 2023 1.86 Mn
Dec 31, 2023 1.86 Mn